Monday, December 19, 2016

BRIEF-UCB and Amgen seek marketing approval of romosozumab in Japan

* Says Amgen and UCB announce submission of

application for investigational osteoporosis medication

romosozumab in Japan

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)